Krsnaa Diagnostics Limited (KRSNAA) Earnings Call Transcripts
Krsnaa Diagnostics Limited's Latest Earnings Call - Q4 FY2026
In Q4 FY '26, Krsnaa Diagnostics Limited reported revenues of approximately INR 1,926 million, reflecting a year-on-year growth of 4%. The company achieved a full-year revenue of INR 7,728 million, up from INR 7,171 million in the previous year. Notably, Krsnaa's PAT for the quarter surged over 101% year-on-year to INR 417 million, contributing to a full-year PAT of INR 1,014 million. Management maintained a cautious outlook for FY '27, projecting revenue contributions from newly established operations in Rajasthan to be between INR 100 crores to INR 150 crores, signaling a more conservative approach to growth expectations.
Reported metrics
| Metric | Value |
|---|---|
| Q4 Revenue | INR 1,926 million (beat) |
| Full-Year Revenue | INR 7,728 million (beat) |
| Q4 PAT | INR 417 million (beat) |
| Full-Year PAT | INR 1,014 million (beat) |
| EBITDA Margin | 29% (positive) |
| CapEx for FY '27 | INR 5,000 million (neutral) |
Guidance from management
Management expects revenue contributions from Rajasthan to be between INR 100 crores to INR 150 crores in FY '27, maintaining a conservative outlook on growth due to ramp-up challenges.
What management said
So in this quarter, there was no contribution of Rajasthan. We were all in the case of establishing the labs and the collection centers. We see Rajasthan contribution coming in from Q1 FY '27. The revenues have started coming up. The entire installation is expected to be completed majorly within Q1 and some bit of it flowing into Q2. So by Q2, we expect all the installations to be completed.
So from an aspiration and the project value perspective, the number that we quoted earlier was good. It is just that considering the ramp up here and from our experience, we'd like to have a conservative approach.
What analysts pressed on
Analysts expressed concerns regarding the slower-than-expected revenue growth and project execution delays, particularly in Maharashtra and Karnataka. There were questions about the sustainability of margins and the impact of government changes on receivables.
Main topics on the call
- Revenue Growth and PAT Surge — Krsnaa reported Q4 revenues of INR 1,926 million, marking a 4% YoY increase, while full-year revenues reached INR 7,728 million. The PAT for the quarter was INR 417 million, up over 101% YoY, with full-year PAT at INR 1,...
- Rajasthan Expansion and Revenue Guidance — Management indicated that revenue from the Rajasthan project is expected to contribute between INR 100 crores to INR 150 crores in FY '27. This cautious guidance reflects a conservative approach to ramp-up expectations a...
- Retail Business Growth — The retail segment now contributes approximately 8% of total revenues, with expectations to scale up to double digits in FY '27. Management emphasized the potential for retail to become a significant growth driver, lever...
- Improvement in Working Capital — Krsnaa reported a reduction in Days Sales Outstanding (DSO) from 155 days to 139 days, indicating improved collections and working capital efficiency. The highest quarterly collections of INR 1,580 million were achieved ...
Read the full Krsnaa Diagnostics Limited transcript (Q4 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.
About Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited (KRSNAA) is a publicly listed company in the Health Care Providers and Services industry, within the Health Care sector. It trades on NSEI and is based in IN. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 14 calls on record spanning February 14, 2023 to May 26, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 14 Krsnaa Diagnostics Limited earnings call transcripts on record, spanning February 14, 2023 to May 26, 2026. Based on this history, Krsnaa Diagnostics Limited reports quarterly. The most recent call on file is dated May 26, 2026. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- KRSNAA
- Exchange
- NSEI
- Country
- IN
- Sector
- Health Care
- Calls on record
- 14
- First call
- February 14, 2023
- Most recent
- May 26, 2026
- Reporting cadence
- quarterly
| Quarter | Date | |
|---|---|---|
| Q4 FY2026 | May 26, 2026 | Read transcript → |
| Q3 FY2026 | Feb 6, 2026 | Read transcript → |
| Q2 FY2026 | Nov 10, 2025 | Read transcript → |
| Q1 FY2026 | Aug 12, 2025 | Read transcript → |
| Q4 FY2025 | May 13, 2025 | Read transcript → |
| Q3 FY2025 | Feb 13, 2025 | Read transcript → |
| Q2 FY2025 | Oct 28, 2024 | Read transcript → |
| Q1 FY2025 | Aug 7, 2024 | Read transcript → |
| Q4 FY2024 | May 21, 2024 | Read transcript → |
| Q3 FY2024 | Feb 13, 2024 | Read transcript → |
| Q2 FY2024 | Nov 6, 2023 | Read transcript → |
| Q1 FY2024 | Aug 17, 2023 | Read transcript → |
| Q4 FY2023 | May 29, 2023 | Read transcript → |
| Q3 FY2023 | Feb 14, 2023 | Read transcript → |